Ixabepilone: new perspectives for its use in breast cancer

by A. A. Mescheryakov, E. V. Lubennikova, M. E. Abramov
Published 2018-11-01

Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer

by N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov
Published 2020-02-01

The prospects for cisplatin and nab-paclitaxel combination therapy in patients with pre-treated triple-negative breast cancer. Description of the clinical case.

by L. G. Zhukova, K. S. Bardovskaya, E. V. Lubennikova, I. R. Suslova
Published 2018-07-01

Ribociclib in 1st line HR+ breast cancer treatment

by L G Zhukova, I P Ganshina, O O Gordeeva, E V Lubennikova
Published 2018-06-01

Opyt dlitel'nogo primeneniya kombinatsii kapetsitabina, lapatiniba i trastuzumabapri HER-2-pozitivnom metastaticheskom rake molochnoy zhelezy. Opisanie klinicheskogo sluchaya

by L G Zhukova, M A Okruzhnova, E V Lubennikova, K R Zeynalova
Published 2011-03-01

Olaparib in the metastatic HER2-negative breast cancer setting

by L. G. Zhukova, E. I. Khatkova, I. P. Ganshina, I. V. Kolyadina, E. V. Lubennikova
Published 2020-12-01

Ribociclib for the treatment of hormone-positive HER2-negative breast cancer

by I. P. Ganshina, D. A. Filonenko, O. O. Gordeeva, E. V. Lubennikova, I. V. Kolyadina, A. A. Mescheryakov
Published 2019-06-01

Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case

by I V Kolyadina, I P Ganshina, L G Zhukova, A G Abdullaev, Yu Yu Andreeva, T Yu Danzanova, G T Sinyukova, D V Komov, N A Kozlov, D A Filonenko, O O Gordeeva, E V Lubennikova
Published 2017-12-01

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer

by O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Ganshina, G. V. Vyshinskaya, M. A. Kazantseva, M. V. Sukhova, O. E. Ryabishina, E. V. Lubennikova, D. A. Filonenko, E. I. Chichikov, I. N. Polushkina, E. I. Borisova, A. N. Lud, A. A. Meshcheryakov
Published 2020-11-01

EXPERIENCE WITH SUBCUTANEOUS TRASTUZUMAB USED IN RUSSIAN FEDERATION

by E. V. Lubennikova, I. P. Ganshina, A. N. Lud, D. V. Komov, I. V. Kolyadina, Y. V. Vishnevskaya, I. K. Vorotnikov, D. L. Stroyakovsky, N. A. Savelov, V. F. Semiglazov, А. G. Manikhas, А. V. Osheychik, T. B. Strelnikova, K. R. Zeynalova, L. G. Zhukova
Published 2017-11-01

Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer

by T. Yu. Semiglazova, E. V. Lubennikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, A. V. Avramenko, E. V. Artemeva, S. A. Borozdina, A. A. Vakhitova, N. M. Volkov, I. P. Ganshina, Sh. A. Dzhalilova, L. G. Zhukova, B. S. Kasparov, A. A. Kachmazov, V. V. Klimenko, A. i. Kornietskaya, A. A. Meshcheryakov, A. A. Paichadze, A. N. Poltoratsky, O. E. Ryabishina, M. L. Stepanova, E. N Imyanitov
Published 2020-12-01